Consensus Ascentage Pharma Group International

Equities

Market Closed - Hong Kong S.E. Other stock markets 04:08:24 2024-07-08 am EDT			5-day change	1st Jan Change
27.15 ^HKD	+0.18%		+6.26%	-0.55%

Jul. 04	Ascentage Grants Takeda Exclusive Option for Licensing of Blood Cancer Drug	MT
Jun. 21	Ascentage Pharma Group Completes $75 Million Share Subscription Deal with Takeda International	MT

08c7.w7FkxAdAFzQGes_TiG-TdCROBm2fM8_xe5P0Tm_MQcY.ioBQ9EAHdmJBCvfg6V_jR256NBf-VYncHN7DJQinFLPwglOzSQFkQ2IMgg~d9cecdb6471d5470fce64abc3c1cb2c9

Ascentage Pharma Chairman Boosts Stake in Firm	Apr. 09	MT
Ascentage Pharma Group Directors Acquire Company Shares	Apr. 03	MT

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

25.27 CNY

Average target price

28.74 CNY

Spread / Average Target

+13.74%

High Price Target

33.24 CNY

Spread / Highest target

+31.57%

Low Price Target

21.25 CNY

Spread / Lowest Target

-15.91%

Trading Rating

Investor Rating

ESG Refinitiv